NDC 0378-6681
Sunitinib Malate
Sunitinib Malate
Sunitinib Malate is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Sunitinib Malate.
| Product ID | 0378-6681_4dbfcc02-dacc-4f0c-9f41-095783b68e27 |
| NDC | 0378-6681 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sunitinib Malate |
| Generic Name | Sunitinib Malate |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-01-04 |
| Marketing Category | ANDA / |
| Application Number | ANDA201275 |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | SUNITINIB MALATE |
| Active Ingredient Strength | 38 mg/1 |
| Pharm Classes | Protein Kinase Inhibitors [MoA],Kinase Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |